Highest-materiality recent filing
Ryan Specialty boosts buyback authorization by $300M to $600M total
Board increased share repurchase program by $300M on May 21, 2026; total authorization now $600M.
All six director nominees elected; David P. Bolger received ~1.23B for, ~2.91M against.
Ryan Specialty Q1 revenue up 15.2%; net income $40.6M vs prior-year loss
Total revenue $795.2M (+15.2% YoY); organic growth 11.8%, down from 12.9% prior-year.
Ryan Specialty enters option settlement for up to $52.3M share repurchases
Trust to sell up to ~$52.3M of Class A common stock to company at May 4 closing price.
Ryan Specialty sets 2026 annual meeting for April 28; record date March 2
Annual meeting date: April 28, 2026; held virtually.
Q4 revenue $751.2M (+13.2% YoY); organic growth 6.6% vs 11.0% prior year.
Board member Bobby Le Blanc to retire Feb. 11, 2026 after Onex sells stake
Robert Le Blanc, Onex CEO, retires from Ryan Specialty Board effective February 11, 2026; mutual agreement.
Ryan Specialty Q3 revenue up 24.8% to $754.6M, organic +15.0%, net income $62.6M
Total revenue $754.6M, +24.8% YoY; organic growth 15.0% (vs 11.8% prior-year).
Ryan Specialty appoints Keogh and Mulshine as Co-Presidents; Bickham advisor
Stephen P. Keogh named Co-President and COO; Brendan M. Mulshine named Co-President and CRO.
Ryan Specialty elects Michael G. Bungert to board; former Aon Re Chairman
Michael G. Bungert joined board effective Sept 3, 2025; assigned to Compensation and Governance Committee.
Ryan Specialty Q2 total revenue $855.2M, +23% YoY; Adj. EPS $0.66, +13.8%; declares $0.12 dividend
Total revenue $855.2M (+23.0% YoY); organic revenue growth 7.1% decelerated from 14.2%.
Ryan Specialty board lead director Cam Findlay dies; successors named
D. Cameron Findlay, board member since 2012 and Lead Director, passed away unexpectedly in July 2025.
Ryan Specialty stockholders approve governance overhaul including Class B vote sunset by Sept 2029
Stockholders approved declassification of Board and phase-in of annual director elections; four nominees elected to three-year terms expiring 2028.
Ryan Specialty Q1 rev up 25% to $690M; GAAP net loss $4.4M; declares $0.12 dividend
Total revenue $690.2M (+25% YoY); organic growth 12.9%.
Ryan Specialty appoints Steve Keogh as COO effective May 1, 2025
Keogh was Senior Advisor to Aon's Office of President and formerly President of Aon's Commercial Risk Solutions.
Ryan Specialty Q4 revenue up 24.5% to $663.5M; Adj. EBITDAC +36.2%; declares $0.12 dividend
Total revenue $663.5M (+24.5% YoY); organic growth 11.0% (vs 16.5% prior year).
On March 27, 2025, Ryan Specialty Holdings, Inc. (the “Company”) announced the appointment of Mr. Stephen P. Keogh to the position of Chief Operating Officer of the Company, effective May 1, 2025.
Max materiality 0.80 · Median 0.65 · Most common event earnings